Related Experiment Video
Updated: Jul 16, 2026

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression
Darin D Dougherty1, Scott L Rauch
1Department of Psychiatry, Massachusetts General Hospital, 15 Parkman Street, Boston, MA 02114, USA. ddougherty@partners.org
Abstract:
Although neutral-state functional neuroimaging studies have improved the understanding of the pathophysiology of major depression, studies that employ state manipulations may provide further information. Such interventions of the effects of acute or chronic pharmacologic treatment. This article has reviewed issues surrounding functional neuroimaging studies of treatment. Because the ultimate goal of psychiatric research is improved understanding of the pathophysiology as well as treatment of mental illness, the proposed contribution of these studies is the development of tests that will guide case management and thus be clinically useful.
More Related Videos
Related Concept Videos
Brain Imaging
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Antidepressant Drugs: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents

